GC Biopharma financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
₩141.98B ₩372.37B ₩366.73B ₩442.30B ₩516.10B ₩643.21B ₩793.05B ₩767.91B ₩811.77B ₩888.17B ₩975.33B ₩1.05T ₩1.20T ₩1.29T ₩1.33T ₩1.36T ₩1.50T ₩1.54T ₩1.71T ₩0.00M ₩0.00M
GM % Gross Margin %
32.10% 35.83% 38.82% 40.65% 39.40% 41.65% 40.49% 33.58% 31.11% 30.82% 31.72% 32.25% 29.30% 28.39% 25.82% 27.34% 29.21% 33.76% 33.89% 0.00% 0.00%
OM Operating Margin
3.25% 9.12% 13.19% 13.17% 13.17% 18.36% 19.69% 11.12% 9.15% 8.87% 9.92% 8.75% 6.55% 7.01% 3.76% 3.07% 3.34% 4.79% 4.72% 0.00% 0.00%
EPS Earnings Per Share
₩10.68k ₩5.28k ₩5.05k ₩4.08k ₩7.26k ₩8.21k ₩5.45k ₩4.67k ₩3.02k ₩-319.00 ₩7.10k ₩10.80k ₩5.74k ₩-100.80 ₩0.00
Div. Dividends
₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩1.43k ₩1.19k ₩1.25k ₩1.25k ₩1.75k ₩1.25k ₩1.25k ₩1000.00 ₩1000.00 ₩1.50k ₩2.00k ₩2.00k ₩1.75k ₩0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 27.05% 23.56% 30.62% 17.22% 21.31% 22.93% 26.80% 33.15% -313.48% 21.14% 18.53% 34.87% -1736.11% 0
Sha. Shares
5.06m 9m 9.09m 9.22m 9.29m 9.44m 10.27m 10.62m 10.62m 11.56m 11.56m 11.56m 11.56m 11.41m 11.41m 11.41m 11.41m 11.41m 11.41m 0m 11.41m
OCF Operating Cash Flow
₩16.34B ₩23.27B ₩27.39B ₩35.22B ₩-20729.14M ₩112.01B ₩84.97B ₩54.86B ₩50.76B ₩29.69B ₩56.76B ₩45.24B ₩-1742.29M ₩57.88B ₩14.41B ₩40.29B ₩35.97B ₩125.98B ₩119.15B ₩0.00M ₩0.00M
FCF Free Cash Flow
₩10.65B ₩3.75B ₩-8957.94M ₩-35710.69M ₩-77922.27M ₩96.91B ₩56.30B ₩11.33B ₩-14463.70M ₩-54035.50M ₩20.81B ₩-41656.86M ₩-35870.84M ₩28.39B ₩-26976.32M ₩-87163.08M ₩-46902.04M ₩23.66B ₩61.16B ₩-33.33M ₩0.00M
FCFS Free Cash Flow Per Share
₩1.63k ₩170.95 ₩-1103.61 ₩-4244.35 ₩-9053.50 ₩9.85k ₩5.71k ₩-13.26 ₩-2244.19 ₩-5340.33 ₩-1206.34 ₩-7814.75 ₩-8678.89 ₩893.73 ₩-4403.45 ₩-9307.38 ₩-5716.82 ₩220.33 ₩4.61k ₩0.00 ₩0.00